期刊
FUTURE MEDICINAL CHEMISTRY
卷 5, 期 5, 页码 553-572出版社
FUTURE SCI LTD
DOI: 10.4155/FMC.13.17
关键词
-
资金
- NIH [R01CA116804]
- St. Baldrick foundation
- MaxCure foundation
- Samuel Waxman Cancer Research foundation
- V foundation
- Georgia State University Center for Diagnostics and Therapeutics
- Molecular Basis of Disease Program
Hypoxia is a significant feature of solid tumor cancers. Hypoxia leads to a more malignant phenotype that is resistant to chemotherapy and radiation, is more invasive and has greater metastatic potential. Hypoxia activates the hypoxia inducible factor (HIF) pathway, which mediates the biological effects of hypoxia in tissues. The HIF complex acts as a transcription factor for many genes that increase tumor survival and proliferation. To date, many HIF pathway inhibitors indirectly affect HIF but there have been no clinically approved direct HIF inhibitors. This can be attributed to the complexity of the HIF pathway, as well as to the challenges of inhibiting protein-protein interactions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据